Imeron

Iomeprol, the active ingredient in Imeron, is an iodinated contrast agent presented as a solution for injection for intrathecal use. It enhances radiodensity during diagnostic imaging procedures such as myelography and cisternography, allowing clearer visualization of spinal and cerebrospinal spaces.

GNH USA supplies Imeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, imaging centres and clinics worldwide. The company ensures consistent quality, regulatory adherence, and reliable logistics for global distribution. Clients benefit from comprehensive technical support and documentation for safe clinical use.

Imeron (iomeprol) is employed in intrathecal diagnostic imaging to improve visualization of central nervous system structures. - Myelography: provides high‑contrast images of the spinal canal and nerve roots, facilitating detection of compressive lesions and disc pathology. - Cisternography: enhances delineation of the subarachnoid space and cerebrospinal fluid pathways, aiding assessment of CSF leaks and ventricular communication. - Other intrathecal diagnostic imaging procedures: supplies contrast enhancement for specialized neuroradiologic studies such as spinal cord angiography.

Imeron may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often occurring shortly after injection. - Nausea: transient feeling of queasiness that usually resolves without treatment. - Vomiting: occasional emesis following the procedure. - Transient back pain: brief discomfort at the injection site. - Flushing: brief skin reddening and warmth. - Dizziness: temporary light‑headedness.

Serious or Rare Side Effects: - Allergic reaction or anaphylaxis: severe hypersensitivity requiring immediate medical intervention. - Seizures: rare neurologic events possibly related to contrast neurotoxicity. - Severe hypotension: sudden drop in blood pressure needing urgent care. - Neurotoxicity: rare cases of spinal cord irritation or arachnoiditis. - Renal impairment: potential worsening of kidney function, especially in at‑risk patients. - Arachnoiditis: inflammation of the arachnoid membrane causing chronic pain.

Prior to using Imeron, clinicians should evaluate patient-specific factors and follow safety guidelines to minimize risks. - Pregnancy: use only if clearly needed, as safety data are limited. - Renal function: assess baseline kidney status; consider alternative agents in severe impairment. - Allergy history: screen for prior reactions to iodinated contrast media or iodine‑containing substances. - Intrathecal administration: ensure strict aseptic technique and correct dosage calculation. - Monitoring: observe the patient during and after injection for immediate adverse reactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Imeron can interact with other medications or substances, influencing safety or efficacy.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents: increases cumulative iodine load and risk of toxicity. - Nephrotoxic drugs (e.g., aminoglycosides, NSAIDs) in patients with compromised renal function: may exacerbate kidney injury. - Iodine‑containing medications (e.g., amiodarone) in patients with thyroid disease: can precipitate thyroid dysfunction.

Moderate Interactions (Monitor Closely): - Diuretics: monitor fluid balance and renal parameters during contrast administration. - ACE inhibitors or ARBs: watch for blood pressure fluctuations and renal effects. - Antihistamines: may mask early signs of an allergic reaction, requiring careful observation.